<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST002324/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><species>Caenorhabditis Elegans</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST002324</full_dataset_link><study_factor>Treatment:ncl-1 RNAi | Days of adulthood:6</study_factor><study_factor>Treatment:tif-IA RNAi | Days of adulthood:2</study_factor><study_factor>Treatment:ctrl RNAi | Days of adulthood:6</study_factor><study_factor>Treatment:tif-IA RNAi | Days of adulthood:6</study_factor><study_factor>Treatment:ctrl RNAi | Days of adulthood:2</study_factor><study_factor>Treatment:ctrl RNAi | Days of adulthood:12</study_factor><study_factor>Treatment:ncl-1 RNAi | Days of adulthood:12</study_factor><study_factor>Treatment:ncl-1 RNAi | Days of adulthood:2</study_factor><study_factor>Treatment:tif-IA RNAi | Days of adulthood:12</study_factor><tissue>Worms</tissue><submitter_affiliation>University of Innsbruck</submitter_affiliation><sample_protocol>Reversed phase NEGATIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>PG(18:1_20:3)</metabolite_name><metabolite_name>LPC(20:4)</metabolite_name><metabolite_name>PS(18:0_18:1)</metabolite_name><metabolite_name>LPE(18:2)</metabolite_name><metabolite_name>PE(18:1_18:2)</metabolite_name><metabolite_name>PE(O-18:0_16:1)</metabolite_name><metabolite_name>PG(18:0_18:2)</metabolite_name><metabolite_name>LPE(16:0)</metabolite_name><metabolite_name>PC(16:1_20:4)</metabolite_name><metabolite_name>PC(18:0_20:3)</metabolite_name><metabolite_name>PC(16:1_18:1)</metabolite_name><metabolite_name>PE(16:0_18:1)</metabolite_name><metabolite_name>PE(18:1_20:5)</metabolite_name><metabolite_name>PI(18:0_20:4)</metabolite_name><metabolite_name>PS(18:1_20:3)</metabolite_name><metabolite_name>PG(18:1_20:4)</metabolite_name><metabolite_name>PS(18:0_20:4)</metabolite_name><metabolite_name>PI(16:1_18:1)</metabolite_name><metabolite_name>PE(O-18:1_18:1)</metabolite_name><metabolite_name>LPE(16:1)</metabolite_name><metabolite_name>PG(18:0_16:1)</metabolite_name><metabolite_name>LPC(20:5)</metabolite_name><metabolite_name>PE(16:0_20:3)</metabolite_name><metabolite_name>PC(18:0_18:1)</metabolite_name><metabolite_name>PC(16:1_20:3)</metabolite_name><metabolite_name>PI(16:0_18:2)</metabolite_name><metabolite_name>PG(18:1_20:5)</metabolite_name><metabolite_name>PI(18:1_18:2)</metabolite_name><metabolite_name>PS(18:0_20:3)</metabolite_name><metabolite_name>LPE(18:0)</metabolite_name><metabolite_name>PE(16:1_20:3)</metabolite_name><metabolite_name>PG(16:1_18:1)</metabolite_name><metabolite_name>PC(16:1_16:1)</metabolite_name><metabolite_name>PC(16:0_18:2)</metabolite_name><metabolite_name>PE(16:0_16:1)</metabolite_name><metabolite_name>PE(18:0_22:4)</metabolite_name><metabolite_name>PI(16:0_18:1)</metabolite_name><metabolite_name>LPE(20:4)</metabolite_name><metabolite_name>PE(18:0_20:2)</metabolite_name><metabolite_name>LPE(18:1)</metabolite_name><metabolite_name>PC(18:0_20:2)</metabolite_name><metabolite_name>PG(16:0_18:1)</metabolite_name><metabolite_name>PC(18:1_20:1)</metabolite_name><metabolite_name>PE(16:1_20:4)</metabolite_name><metabolite_name>PE(16:1_18:1)</metabolite_name><metabolite_name>PE(16:0_16:0)</metabolite_name><metabolite_name>LPC(14:0)</metabolite_name><metabolite_name>LPE(20:5)</metabolite_name><metabolite_name>PC(16:0_16:1)</metabolite_name><metabolite_name>PE(16:0_18:2)</metabolite_name><metabolite_name>PC(O-18:0_16:1)</metabolite_name><metabolite_name>PC(18:0_16:1)</metabolite_name><metabolite_name>PC(16:0_20:3)</metabolite_name><metabolite_name>PC(18:1_18:1)</metabolite_name><metabolite_name>PI(18:0_16:1)</metabolite_name><metabolite_name>PE(18:0_18:1)</metabolite_name><metabolite_name>PG(16:0_16:0)</metabolite_name><metabolite_name>PI(18:1_20:5)</metabolite_name><metabolite_name>PC(18:1_20:4)</metabolite_name><metabolite_name>PE(18:1_20:1)</metabolite_name><metabolite_name>LPC(16:1)</metabolite_name><metabolite_name>PC(O-18:1_18:1)</metabolite_name><metabolite_name>PG(16:0_18:2)</metabolite_name><metabolite_name>PC(O-18:0_18:2)</metabolite_name><metabolite_name>PI(18:1_18:1)</metabolite_name><metabolite_name>PG(18:1_18:2)</metabolite_name><metabolite_name>PI(18:0_18:2)</metabolite_name><metabolite_name>PC(16:0_20:4)</metabolite_name><metabolite_name>PG(16:0_16:1)</metabolite_name><metabolite_name>PI(18:1_20:4)</metabolite_name><metabolite_name>PC(18:1_20:3)</metabolite_name><metabolite_name>PE(18:0_20:3)</metabolite_name><metabolite_name>LPC(16:0)</metabolite_name><metabolite_name>LPE(20:3)</metabolite_name><metabolite_name>LPG(18:1)</metabolite_name><metabolite_name>LPC(18:2)</metabolite_name><metabolite_name>PC(16:0_18:1)</metabolite_name><metabolite_name>LPE(14:0)</metabolite_name><metabolite_name>PG(18:1_18:1)</metabolite_name><metabolite_name>PS(18:1_20:4)</metabolite_name><metabolite_name>PE(14:0_16:0)</metabolite_name><metabolite_name>PI(18:0_18:1)</metabolite_name><metabolite_name>PE(18:0_16:1)</metabolite_name><metabolite_name>PC(18:0_18:2)</metabolite_name><metabolite_name>PE(18:1_20:3)</metabolite_name><metabolite_name>LPC(18:1)</metabolite_name><metabolite_name>PE(O-18:2_18:0)</metabolite_name><metabolite_name>LPC(20:3)</metabolite_name><metabolite_name>PI(18:0_20:2)</metabolite_name><metabolite_name>PS(18:1_20:5)</metabolite_name><metabolite_name>PS(18:1_18:1)</metabolite_name><metabolite_name>PI(18:1_20:1)</metabolite_name><metabolite_name>PG(14:0_16:0)</metabolite_name><metabolite_name>PE(18:1_18:1)</metabolite_name><metabolite_name>PG(18:0_18:1)</metabolite_name><metabolite_name>PS(18:0_18:2)</metabolite_name><metabolite_name>PC(18:1_18:2)</metabolite_name><metabolite_name>PE(18:0_18:2)</metabolite_name><metabolite_name>PG(14:0_18:1)</metabolite_name><metabolite_name>PC(18:1_20:5)</metabolite_name><metabolite_name>LPC(18:0)</metabolite_name><metabolite_name>PI(18:0_20:3)</metabolite_name><data_protocol></data_protocol><name_synonyms>CG16938, Tif-1A, a phospholipid derivative, New calpain 1, DmelCG3278, CANP 3., Phospholipid, TIF-IA, CANPL3, p94, phospholipids, RnBP, GlcNAc 2-epimerase, nCL-1, Phosphatides, TifIA, Calpain L3, CANP3, LGMD2A, Calcium-activated neutral proteinase 3, AGE, N-acetyl-D-glucosamine 2-epimerase, Muscle-specific calcium-activated neutral protease 3, 3.4.22.54, RENBP, Transcription initiation factor IA, TIF-1A, LGMD2, renin-binding protein, CG3278, CG5951, dTIF-IA, Calpain p94</name_synonyms><sample_synonyms>backward, reversed.</sample_synonyms></additional><is_claimable>false</is_claimable><name>Exploration of age-dependent changes of phospholipid profiles in C. elegans depleted of tif-IA and ncl-1</name><description/><dates><publication></publication></dates><accession>ST002324</accession><cross_references><TAXONOMY>6239</TAXONOMY></cross_references></HashMap>